Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -22.755% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a) CC1Cc2ccccc2N1C(=O)CCS(=O)(=O)c1cccs1
b) CCN1CCN(c2cc(=O)n(C3CCCCC3)c(=O)[nH]2)CC1
c) Cc1cc2c(cc1C)NC(=O)CC(C(F)(F)C(F)(F)C(F)(F)F)=N2
d) CCOc1ccc(C2=CSC3=NCCN23)cc1Cl
Answer: d. CCOc1ccc(C2=CSC3=NCCN23)cc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(C2=CSC3=NCCN23)cc1Cl
CCOc1ccc(C2=CSC3=NCCN23)cc1Cl
3-(3-chloro-4-ethoxyphenyl)-5,6-dihydroimidazo[2,1-b][1,3]thiazole